Marc M. Schellekens

835 citations

21 papers · 695 indexed · h-index 15

Virology top 5%
- HIV Research and Treatment 4
Immunology top 10%
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 5
- Immune Response and Inflammation 4
Pathology and Forensic Medicine
Radiology, Nuclear Medicine and Imaging top 10%
- Monoclonal and Polyclonal Antibodies Research 8
Immunology and Allergy
Molecular Biology
- Glycosylation and Glycoproteins Research 3
- Chemical Synthesis and Analysis 1
Infectious Diseases
- HIV/AIDS drug development and treatment 2

Co-authors: Eric Claassen Jon D. Laman W.J.A. Boersma Marjan van Meurs Bert A. ‘t Hart Mark de Boer Jan Ceuppens Herbert Brok
Cited by: Virology Immunology Pathology and Forensic Medicine
Partner nations: Netherlands Austria United States

In The Last Decade

Marc M. Schellekens

21 papers receiving 667 citations

Peers

Countries citing papers authored by Marc M. Schellekens

Since Specialization

Citations

This map shows the geographic impact of Marc M. Schellekens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc M. Schellekens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc M. Schellekens more than expected).

Fields of papers citing papers by Marc M. Schellekens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc M. Schellekens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc M. Schellekens. The network helps show where Marc M. Schellekens may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marc M. Schellekens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc M. Schellekens Line = papers co-authored together Marc M. Schellekens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Unobtrusive ECG monitoring in the NICU using a capacitive sensing array Louis Atallah,Aline Serteyn,Mohammed Meftah,Marc M. Schellekens,Rik Vullings,J.W.M. Bergmans,A Osagiator,Sidarto Bambang Oetomo	2014	41
2	Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens C.B.M. Maassen,Jon D. Laman,Conny van Holten-Neelen,Linsy Hoogteijling,Lizet Groenewegen,L. H. Visser,Marc M. Schellekens,W.J.A. Boersma,Eric Claassen	2003	25
3	Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12) Jon D. Laman,Bert A. ‘t Hart,Herbert Brok,Marjan van Meurs,Marc M. Schellekens,Ahmad Kasran,Louis Boon,Jan Bauer,Mark de Boer,Jan Ceuppens	2002	53
4	Prevention of Experimental Autoimmune Encephalomyelitis in the Common Marmoset ( Callithrix jacchus ) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses Louis Boon,Herbert Brok,Jan Bauer,Antonio Ortiz-Buijsse,Marc M. Schellekens,Seema Ramdien‐Murli,Erwin L. A. Blezer,Marjan van Meurs,Jan Ceuppens,Mark de Boer,Bert A. ‘t Hart,Jon D. Laman	2001	93
5	Novel monoclonal antibodies against proteolipid protein peptide 139–151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions Jon D. Laman,L. H. Visser,C.B.M. Maassen,Corline J.A. De Groot,Laurina A. de Jong,Bert A. ‘t Hart,Marjan van Meurs,Marc M. Schellekens	2001	13
6	Recognition Properties of V3-Specific Antibodies to V3 Loop Peptides Derived from HIV-1 gp120 Presented in Multiple Conformations J Huisman,Alfonso Carotenuto,Aran F. Labrijn,Christina H. M. Papavoine,Jon D. Laman,Marc M. Schellekens,Marco Koppelman,C.W. Hilbers	2000	5
7	Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus) Jon D. Laman,Marjan van Meurs,Marc M. Schellekens,Mark de Boer,Bert P.C. Melchers,Luca Massacesi,Hans Lassmann,Eric Claassen,Bert A. ‘t Hart	1998	76
8	Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide Jon D. Laman,C.B.M. Maassen,Marc M. Schellekens,L Visser,Marcel Kap,E. de Jong,Marjo van Puijenbroek,M JB van Stipdonk,Marjan van Meurs,Christoph Schwärzler,Ursula Günthert	1998	49
9	Fluorescent labelling of virus, bacteria and iscoms: in vivo systemic and mucosal localisation patterns. Ivo Claassen,Albert D. M. E. Osterhaus,W.J.A. Boersma,Marc M. Schellekens,E Claassen	1995	8
10	A Hidden Region in the Third Variable Domain of HIV-1 IIIB gp120 Identified by a Monoclonal Antibody Jon D. Laman,Marc M. Schellekens,George K. Lewis,John P. Moore,Thomas J. Matthews,J P Langedijk,Rob H. Meloen,W.J.A. Boersma,Eric Claassen	1993	18
11	Differential Uptake and Trapping of TI-2 Antigens: an Unexpected Role for Follicular Dendritic Cells in the Induction of TI-2 Immune Responses Alfons J.M. van den Eertwegh,Marc M. Schellekens,W.J.A. Boersma,Eric Claassen	1993	5
12	Complement‐mediated follicular localization of T‐independent type‐2 antigens: the role of marginal zone macrophages revisited Alfons J.M. van den Eertwegh,Jon D. Laman,Marc M. Schellekens,W.J.A. Boersma,Eric Claassen	1992	52
13	Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain Jon D. Laman,Marc M. Schellekens,Hakan Abacıoğlu,George K. Lewis,M Tersmette,Ron A. M. Fouchier,J P Langedijk,Eric Claassen,W.J.A. Boersma	1992	65
14	The isolation of monoclonal antibodies selected for the detection of imidazole ring-opened N7-ethylguanine in purified DNA and in cells in situ. Crossreaction with methyl, 2-hydroxethyl and sulphur mustard adducts Joost H.M. van Delft,E.J.M. van Weert,Marc M. Schellekens,Eric Claassen,Robert A. Baan	1991	23
15	In vivo kinetics and characterization of IFN-gamma-producing cells during a thymus-independent immune response Alfons J. van den Eertwegh,M Fasbender,Marc M. Schellekens,A. van Oudenaren,W.J.A. Boersma,Eric Claassen	1991	32
16	Oral administration of TNP-Lactobacillus conjugates in mice: A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli Koen Gerritse,M. Posno,Marc M. Schellekens,W.J.A. Boersma,Eric Claassen	1990	44
17	Specific immuno-detection of benzoate-para-hydroxylase with antibodies raised against synthetic peptides Koen Gerritse,Robert Van Gorcom,M Fasbender,Jacqueline Lange,Marc M. Schellekens,Netty D. Zegers,Eric Claassen,W.J.A. Boersma	1990	4
18	Marginal zone of the murine spleen in autotransplants: functional and histological observations in the response against a thymus-independent type 2 antigen. Eric Claassen,Alewijn Ott,W.J.A. Boersma,C. Deen,Marc M. Schellekens,C.D. Dijkstra,N. Kors,Nico van Rooijen	1989	25
19	Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages. Eric Claassen,Y Westerhof,B. Versluis,N. Kors,Marc M. Schellekens,Nico van Rooijen	1988	16
20	A three-dimensional description of heating patterns in vascularised tissues during hyperthermic treatment J J W Lagendijk,Marc M. Schellekens,J. Schipper,P.M. van der Linden	1984	46

About Marc M. Schellekens

Marc M. Schellekens is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 695 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers), HIV Research and Treatment (4 papers), Immune Response and Inflammation (4 papers), Glycosylation and Glycoproteins Research (3 papers), HIV/AIDS drug development and treatment (2 papers) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Virology (83 citations), Immunology (354 citations) and Pathology and Forensic Medicine (102 citations). Marc M. Schellekens has collaborated with scholars based in Netherlands, Austria and United States. Frequent co-authors include Eric Claassen, Jon D. Laman, W.J.A. Boersma, Marjan van Meurs, Bert A. ‘t Hart, Mark de Boer, Jan Ceuppens, Herbert Brok, Jan Bauer and Louis Boon.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact